INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-17-00774

Ultra-low contrast percutaneous coronary intervention in patients with severe chronic kidney disease

Lorenzo Azzalini*, MD, PhD, MSc; Daisuke Hachinohe, MD; Damiano Regazzoli, MD; Antonio Colombo, MD

Figure 1. Ultra-low contrast PCI. A) Coronary angiography demonstrates a long and tortuous lesion in the distal circumflex. B) Predilatation with 2.5×30 mm semi-compliant balloon. The asterisk indicates the wire advanced into a small side branch and used to create a “roadmap” for PCI. C) OCT shows extensive calcification (arrowheads) and multiple dissection planes (cross-sections at the levels indicated in panel A). D) Atherectomy with 2.5 mm scoring balloon (arrow indicates mother-and-child catheter). E) Implantation of 3.5-3.0×50 mm sirolimus-eluting stent. F) OCT imaging shows major malapposition (arrows) of the stent at the distal edge (corresponding to the level indicated in panel G). Good final angiographic (G) and OCT (H) result after repeat high-pressure post-dilatation.

A 52-year-old man with a prior kidney transplant and chronic kidney disease (CKD) (baseline creatinine 2.7 mg/dl; estimated glomerular filtration rate [eGFR] 25 ml/min/1.73 m2) presented with angina. Coronary angiography demonstrated two-vessel disease, with a long and tortuous lesion in the distal circumflex and diffuse disease in the distal left anterior descending, which was not considered to be amenable to treatment (Figure 1A, Moving image 1). The patient was referred for percutaneous coronary intervention (PCI) on the circumflex.

Our ultra-low contrast (ULC) PCI protocol is used in patients with eGFR <30 ml/min/1.73 m2 and comprises the use of: 1) ioversol, a low-osmolar contrast medium, diluted at 50%, and used only in key moments of the procedure (e.g., to confirm the final result); 2) side branch wiring to create a “roadmap” for PCI; 3) optical coherence tomography (OCT) with dextran 40 (instead of contrast) to guide PCI (flow rate: 4.0 ml/s, total volume: 14.0 ml, pressure: 400 psi, rise time: 0.0 s). Additionally, patients receive hydration with isotonic saline (1.5 ml/kg/hr for 12 hours before and 24 hours after PCI).

A 6 Fr XB 3.5 guiding catheter was inserted transradially to engage the left main. Two wires were placed in the distal circumflex and one of its branches. After a small balloon was advanced with difficulty (due to marked tortuosity) and predilatation was performed (Figure 1B), a mother-and-child catheter was advanced into the distal circumflex. Dextran-based OCT was performed and revealed extensive calcification (Figure 1C, Moving image 2). Scoring balloon angioplasty was performed (Figure 1D), and a 3.5-3.0×50 mm sirolimus-eluting stent (BioMime Morph™; Meril Life Sciences Pvt., Vapi, India) was implanted (Figure 1E) and post-dilated. Repeat OCT showed major stent malapposition at the distal edge (Figure 1F), which was resolved with repeat high-pressure post-dilatation. Final angiographic (Figure 1G, Moving image 3) and OCT (Figure 1H, Moving image 4) results were good. Contrast volume was 12.5 ml, fluoroscopy time 35 min, and radiation dose 65 Gy·cm2. Creatinine at 48 and 72 hours remained at 2.7 mg/dl. At 30-day follow-up, the patient was asymptomatic and had not suffered any hospitalisation.

The incidence of contrast-induced nephropathy (CIN) in patients with severe CKD is high (26.6%), and its consequences devastating, including a high risk of in-hospital mortality (9.7%)1. CKD subjects undergo PCI less frequently than non-CKD patients, due to aversion to the risk of CIN. In such a setting, the implementation of ULC-PCI protocols is warranted. Diluted contrast is a feasible option to reduce contrast volume in PCI while maintaining sufficient image quality2. Dextran has been shown to be effective and safe for blood flushing during OCT3. Zero-contrast4 and low-contrast2 PCI protocols based on intravascular ultrasound (IVUS) have the potential to decrease the incidence of CIN, although IVUS significantly prolongs these procedures and has lower resolution compared with OCT. Additionally, a zero-contrast approach might prevent the prompt diagnosis of life-threatening complications, such as distal-vessel perforation. Therefore, ULC-PCI based on diluted contrast and dextran-based OCT appears to be an appealing option in patients with advanced CKD and deserves further investigation.

Conflict of interest statement

L. Azzalini reports grants from ACIST Medical Systems, and personal fees from Guerbet, outside the submitted work. The other authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Baseline coronary angiogram (non-diluted contrast).

Moving image 2. Dextran-based optical coherence tomography after predilatation.

Moving image 3. Final angiographic result (diluted contrast).

Moving image 4. Final dextran-based optical coherence tomography.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Baseline coronary angiogram (non-diluted contrast).

Moving image 2. Dextran-based optical coherence tomography after predilatation.

Moving image 3. Final angiographic result (diluted contrast).

Moving image 4. Final dextran-based optical coherence tomography.

Volume 14 Number 8
Oct 19, 2018
Volume 14 Number 8
View full issue


Key metrics

On the same subject

Clinical research

10.4244/EIJ-D-20-00539 Aug 27, 2021
Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis
Nakamura D et al
free

Clinical Research

10.4244/EIJ-D-21-00504 Mar 18, 2022
Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules
Tada T et al
free
Trending articles
281.88

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved